A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
Clinical trial NCT05831111 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05831111
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2026-10-13
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.